Ananda Pharma (STU:1FX) Interest Expense : €-0.17 Mil (TTM As of Jul. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Ananda Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ananda Pharma's interest expense for the six months ended in Jul. 2024 was € -0.17 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jul. 2024 was €-0.17 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ananda Pharma's Operating Income for the six months ended in Jul. 2024 was € -1.27 Mil. Ananda Pharma's Interest Expense for the six months ended in Jul. 2024 was € -0.17 Mil. Ananda Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ananda Pharma Interest Expense Historical Data

The historical data trend for Ananda Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma Interest Expense Chart

Ananda Pharma Annual Data

Trend

Jan19

Jan20

Jan21

Jan22

Jan23

Interest Expense

-0.28

Ananda Pharma Semi-Annual Data
	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jul24
Interest Expense	Get a 7-Day Free Trial							-	-	-0.28	-0.05	-0.17

Ananda Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jul. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.17 Mil.

Ananda Pharma (STU:1FX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ananda Pharma's Interest Expense for the six months ended in Jul. 2024 was €-0.17 Mil. Its Operating Income for the six months ended in Jul. 2024 was €-1.27 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jul. 2024 was €0.00 Mil.

Ananda Pharma's Interest Coverage for the quarter that ended in Jul. 2024 is calculated as

Ananda Pharma did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Ananda Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ANA:UK

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.anandapharma.co.uk

Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines